Literature DB >> 6269351

In vitro inhibition of cyclic 3' 5',-AMP-phosphodiesterase by a group of structural analogues of glaucine.

V Petkov, S Stancheva.   

Abstract

Both glaucine and six of its structural analogues applied in increasing concentrations produced a concentration-dependent inhibiton of cyclic 3' 5'-AMP-phosphodiesterase in homogenates from different organs of guinea-pigs and rats. At one and the same concentration of the compound tested the percentage of inhibition varied within wide ranges depending on the compound used, as well as on the organ and on the Km of phosphodiesterase. The changes in the chemical structure of glaucine and the changes in the inhibitory effects on phosphodiesterase activity of tissue homogenates were compared. Some of the compounds applied in appropriate concentrations showed a twice higher inhibitory activity than glaucine. This finding is of particular importance having the mind the much lower toxicity of these compounds compared with glaucine. Essential differences in the dynamics of the concentration-dependent phosphodiesterase inhibition between the compounds were established. The observed peculiarities of the inhibitory effects of the compounds tested favour the concept of the multiple nature of phosphodiesterase. The data from the pharmacological investigation on glaucine and its semisynthetic analogues led us to believe that the effect of 2 compound on phosphodiesterase activity of homogenates from intestinal smooth muscles does not justify any definitive conclusions about the character of its effect on the smooth-muscle activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6269351

Source DB:  PubMed          Journal:  Acta Physiol Pharmacol Bulg        ISSN: 0323-9950


  2 in total

1.  Study of the mechanism of the relaxant action of (+)-glaucine in rat vas deferens.

Authors:  F Orallo; A Fernández Alzueta; M I Loza; N Vivas; A Badía; M Campos; M A Honrubia; M I Cadavid
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

2.  Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.

Authors:  F Orallo; A Fernández Alzueta; M Campos-Toimil; J M Calleja
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.